Bi

12/12 Ventures partners with scalable cannabis companies that build trusted brands. Their investment approach mirrors the patient growth of a cannabis plant, focusing on long-term value creation. They differentiate themselves through extensive experience, a strong track record, and a powerful strategic partner.

1818 Venture Capital is a firm focused on early and growth stage digital technology companies, typically investing early and personally in every opportunity. They partner with companies showing significant growth potential and founders with the vision to achieve it, providing capital and active support.

2048 Ventures is a thesis-driven earliest stage venture capital firm focused on backing visionary founders building technologies of the future.

3TS Capital Partners is a leading European technology-focused private equity and venture capital firm. They provide expansion capital and buyout funding for small and medium-sized businesses in growth sectors. 3TS experts become active business partners for portfolio companies, delivering substantial value beyond financing.

4BIO Capital is a London-based venture capital firm focused solely on the advanced therapies sector. It invests in, supports, and grows early-stage companies developing treatments in areas of high unmet medical need. The firm's team comprises leading advanced therapy scientists and experienced life science investors.

5AM Ventures is a leading life science venture capital firm focused on funding and building next-generation life sciences companies. They primarily invest in early-stage private therapeutic companies, with an emphasis on Series A, and also invest in small and mid-cap public and later-stage private biotech and life science companies.

83North is a global venture capital firm with over $2.2B under management. The fund invests across all stages in exceptional entrepreneurs building global category-leading companies. They have a unique approach to helping companies scale.

Abies Ventures invests in deep tech startups with unique technologies and high aspirations, primarily in Japan and the United States. They support the creation and development of startups solving global-scale problems, leveraging a prominent global network.

Abstract is a venture capital firm based in San Francisco with $1.5 billion in assets under management. They are sector-agnostic and invest in seed and early-stage companies. Their focus is on fierce loyalty, unparalleled connections, and helping founders win.

AC Ventures is an early-stage technology venture fund focusing on Indonesian and ASEAN tech-enabled businesses. They prioritize environmental and social impact, providing entrepreneurs with capital and operational expertise. The firm aims to empower founders and build world-class companies.

Accenture Ventures partners with growth-stage startups that create innovative and disruptive enterprise technologies using an open innovation.

Aera VC invests in early stage ventures building transformative technology to reverse climate change and accelerate the world towards a sustainable future.